Parenteral Nutrition Support for Patients With Pancreatic Cancer

CONKO-Studiengruppe

Status and phase: Completed; Phase 2

Conditions: Cancer Cachexia; Pancreatic Cancer

Treatments: Dietary Supplement: parenteral nutrition

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00919659

C25.0

Details and patient eligibility

About

The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.

Full description

To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.

Enrollment: 32 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• histological proved pancreatic cancer
• progressive cancer cachexia
• refractive to enteral supplementation
• informed consent

Exclusion criteria

• prefinal status
• septic disease

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

32 participants in 1 patient group

parenteral nutrition

Experimental group

Description:

25kcal/kg/bw /day via parenteral support

Treatment:

Dietary Supplement: parenteral nutrition